[go: up one dir, main page]

DK0695172T3 - Fast præparat med hurtig frigørelse, dets fremstilling og dets anvendelse - Google Patents

Fast præparat med hurtig frigørelse, dets fremstilling og dets anvendelse

Info

Publication number
DK0695172T3
DK0695172T3 DK94911799T DK94911799T DK0695172T3 DK 0695172 T3 DK0695172 T3 DK 0695172T3 DK 94911799 T DK94911799 T DK 94911799T DK 94911799 T DK94911799 T DK 94911799T DK 0695172 T3 DK0695172 T3 DK 0695172T3
Authority
DK
Denmark
Prior art keywords
preparation
fast
release solid
active agent
solid preparation
Prior art date
Application number
DK94911799T
Other languages
English (en)
Inventor
Jean Paul Remon
Original Assignee
Univ Gent
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Gent filed Critical Univ Gent
Application granted granted Critical
Publication of DK0695172T3 publication Critical patent/DK0695172T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK94911799T 1993-04-22 1994-04-21 Fast præparat med hurtig frigørelse, dets fremstilling og dets anvendelse DK0695172T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE9300407A BE1006990A5 (nl) 1993-04-22 1993-04-22 Werkwijze en samenstelling om een aktief bestanddeel in een vaste toedieningsvorm te brengen.
PCT/BE1994/000029 WO1994023700A1 (en) 1993-04-22 1994-04-21 High release solid preparation, preparation and use thereof

Publications (1)

Publication Number Publication Date
DK0695172T3 true DK0695172T3 (da) 1998-08-24

Family

ID=3886999

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94911799T DK0695172T3 (da) 1993-04-22 1994-04-21 Fast præparat med hurtig frigørelse, dets fremstilling og dets anvendelse

Country Status (12)

Country Link
US (1) US6368634B1 (da)
EP (1) EP0695172B1 (da)
JP (1) JP2960169B2 (da)
AT (1) ATE161174T1 (da)
AU (1) AU6421594A (da)
BE (1) BE1006990A5 (da)
CA (1) CA2161016A1 (da)
DE (1) DE69407404T2 (da)
DK (1) DK0695172T3 (da)
ES (1) ES2113095T3 (da)
GR (1) GR3026338T3 (da)
WO (1) WO1994023700A1 (da)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ260408A (en) 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
DE4318577A1 (de) * 1993-06-04 1994-12-08 Merck Patent Gmbh Schmiermittelfreie, arzneimittelhaltige Tabletten
US5773025A (en) * 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
CA2159419C (en) * 1994-10-17 2006-07-04 Pieter De Haan Solid pharmaceutical composition comprising an excipient capable of binding water
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
NZ270439A (en) * 1995-02-02 1996-04-26 Bernard Charles Sherman Solid slow release pharmaceutical composition: carrier is polyethylene glycol and hydrophilic gel-forming polymer
TWI225402B (en) * 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
DE69739165D1 (de) 1996-07-08 2009-01-29 Penwest Pharmaceuticals Co Matrix mit verzögerter freisetzung für hochdosierte unlösliche arzneistoffe
JP2002528042A (ja) * 1997-10-07 2002-08-27 フイズ テクノロジーズ リミテッド 改善された放出特性を有する投与形態
US6056977A (en) 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
FR2775597B1 (fr) * 1998-03-04 2001-04-20 Gattefosse Ets Sa Pellet administrable par voie orale apte a ameliorer la biodisponibilite de la substance active, procede de fabrication
WO2000024380A1 (en) * 1998-10-27 2000-05-04 Fuisz Technologies Ltd. Microparticles containing peg and/or peg glyceryl esters
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
WO2001078725A2 (en) * 2000-04-13 2001-10-25 Synthon B.V. Modified release formulations containing a hypnotic agent
SE0200154D0 (sv) * 2002-01-21 2002-01-21 Galenica Ab New process
AU2003211267A1 (en) * 2002-02-27 2003-09-09 Shionogi And Co., Ltd. Solid preparations with improved absorbability of hardly water-soluble drug
GB0205253D0 (en) * 2002-03-06 2002-04-17 Univ Gent Immediate release pharmaceutical granule compositions and a continuous process for making them
US20060003002A1 (en) * 2003-11-03 2006-01-05 Lipocine, Inc. Pharmaceutical compositions with synchronized solubilizer release
US20070190141A1 (en) * 2006-02-16 2007-08-16 Aaron Dely Extended release opiate composition
GB0612695D0 (en) * 2006-06-27 2006-08-09 Univ Gent Process for preparing a solid dosage form
WO2008021666A2 (en) * 2006-08-18 2008-02-21 Morton Grove Pharmaceuticals, Inc. Stable liquid levetiracetam compositions and methods
WO2009114365A2 (en) * 2008-03-13 2009-09-17 Mallinckrodt Inc. Multi-function, foot-activated controller for imaging system
US11304960B2 (en) * 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US20110150986A1 (en) * 2009-12-18 2011-06-23 Kristin Arnold Quinine formulations, method of making, and metho of use thereof
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
US20160361322A1 (en) 2015-06-15 2016-12-15 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
US11559530B2 (en) 2016-11-28 2023-01-24 Lipocine Inc. Oral testosterone undecanoate therapy
CA3107214A1 (en) 2018-07-20 2020-01-23 Lipocine Inc. Liver disease
WO2020262536A1 (en) 2019-06-26 2020-12-30 Ricoh Company, Ltd. Instantly soluble particle and method for producing the same
JPWO2020261619A1 (da) 2019-06-26 2020-12-30

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3146167A (en) * 1961-10-05 1964-08-25 Smith Kline French Lab Method of preparing sustained release pellets and products thereof
GB1148802A (en) * 1965-06-18 1969-04-16 Eastman Kodak Co Microcrystalline cellulose granules containing useful oils
CH523017A (de) * 1969-11-21 1972-05-31 Agripat Sa Schädlingsbekämpfungsmittel
US3655864A (en) * 1970-09-21 1972-04-11 Smith Kline French Lab Glyceryl tristerate and higher fatty acid mixture for improving digestive absorption
GB1367608A (en) * 1973-03-09 1974-09-18 Biolog Concepts Inc Oral pharmaceutical dosage form
USRE33963E (en) * 1981-10-29 1992-06-16 Bayer Aktiengesellschaft Solid rapidly released medicament preparations containing dihydropyridines, and processes for their preparation
FR2581541B1 (fr) * 1985-05-09 1988-05-20 Rhone Poulenc Sante Nouvelles compositions pharmaceutiques permettant la liberation prolongee d'un principe actif et leur procede de preparation
LU86099A1 (fr) * 1985-09-30 1987-04-02 Pharlyse Formes galeniques a liberation prolongee du verapamil,leur fabrication et medicaments les contenant
SE8601624D0 (sv) * 1986-04-11 1986-04-11 Haessle Ab New pharmaceutical preparations
DD249186A1 (de) * 1986-05-26 1987-09-02 Univ Halle Wittenberg Herstellungsverfahren einer neuen glibenclamid-arzneiform mit hoher bioverfuegbarkeit
ATE68704T1 (de) * 1986-12-18 1991-11-15 Bauer Kurt Heinz Gegenueber lichteinfluss stabilisiertes nifedipin- konzentrat und verfahren zu seiner herstellung.
AR240018A1 (es) * 1987-10-07 1990-01-31 Merrell Pharma Inc Procedimiento para preparar una composicion que comprende derivados de piperidinoalcanol.
HU203041B (en) * 1989-03-14 1991-05-28 Egyt Gyogyszervegyeszeti Gyar Process for producing pharmaceutical compositions of controlled releasing factor containing nifedipin
EP0418596A3 (en) 1989-09-21 1991-10-23 American Cyanamid Company Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
US5169645A (en) * 1989-10-31 1992-12-08 Duquesne University Of The Holy Ghost Directly compressible granules having improved flow properties
SE9003296L (sv) * 1990-10-16 1992-04-17 Kabi Pharmacia Ab Foerfarande foer att formulera laekemedel
US5288505A (en) * 1991-06-26 1994-02-22 Galephar P.R., Inc., Ltd. Extended release form of diltiazem
JPH0597672A (ja) * 1991-10-08 1993-04-20 Terumo Corp アミド誘導体含有固形製剤およびその製造方法

Also Published As

Publication number Publication date
JPH09500093A (ja) 1997-01-07
US6368634B1 (en) 2002-04-09
EP0695172B1 (en) 1997-12-17
DE69407404T2 (de) 1998-07-02
EP0695172A1 (en) 1996-02-07
CA2161016A1 (en) 1994-10-27
GR3026338T3 (en) 1998-06-30
WO1994023700A1 (en) 1994-10-27
ES2113095T3 (es) 1998-04-16
AU6421594A (en) 1994-11-08
DE69407404D1 (de) 1998-01-29
BE1006990A5 (nl) 1995-02-07
JP2960169B2 (ja) 1999-10-06
ATE161174T1 (de) 1998-01-15

Similar Documents

Publication Publication Date Title
DK0695172T3 (da) Fast præparat med hurtig frigørelse, dets fremstilling og dets anvendelse
EP1139753A4 (en) PREPARATIONS FOR THE TREATMENT OF DISEASES AND METHODS RELATED THERETO
BR9713866A (pt) Composição farmacéutica
GB9416600D0 (en) Pharmaceutical formulation
MXPA97002401A (es) Agente antiinflamatorio para uso externo.
AR003908A1 (es) Tableta de liberacion controlada
DE3583799D1 (de) Feste zubereitung mit langsamer freisetzung.
PL318789A1 (en) Sprayable film-forming system capable to release an active substance contained in them and intended to use them on plants
EE03202B1 (et) Intravaginaalne manustussüsteem ja selle valmistamismeetod
GR3036548T3 (en) Apparatus and method for preparing solid forms with controlled release of the active ingredient
MX9304975A (es) Una composicion en polvo para inhalacion y procedimiento para preparar la misma.
CA2065210A1 (en) Controlled release matrix for pharmaceuticals
MX9605678A (es) Produccion de composiciones de sustancia activa en forma de una solucion solida de la sustancia activa en una matriz de polimero, y composiciones de sustancia activa producidas por este procedimiento.
DK0697858T3 (da) Nasalt medikamentafgivelsessystem indeholdende nikotin
GT199800126A (es) Terapia de combinacion.
HUP0000143A2 (hu) Kétfázisú eljárások esszenciális aminosavak felhalmozódásának növelésére magokban
DK0711140T3 (da) Antimykotisk opløsning til negle
YU48666B (sh) Mometason furoat monohidrat i postupak za njegovo dobijanje
MX9707570A (es) Utilizacion de agonistas de alta1l para el tratamiento de la incontinencia urinaria.
HRP920960B1 (en) Solutionless pharmaceutical preparations for oral use retardely releasing an active substance and a process for the preparation thereof
DE69431162D1 (en) Fenbendazolformulierungen
EE03224B1 (et) Prolongeeritud toimega süstesuspensioonid ja nende valmistamismeetod
ES2120514T3 (es) Formulacion solida para la proteccion de cultivos.
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
ATE300606T1 (de) Waschmittelformkörper mit verbesserten auflöseeigenschaften